Company intelligence / Profile preview

Kensey Nash

Exton, Pennsylvania, United States6sense.com ↗

Ownership: Private
Employees: ~325
Development stage: Commercial

Overview

Kensey Nash developed and commercialized leading medical devices for vascular closure, notably the Angio-Seal Vascular Closure Device, as well as a broad portfolio of regenerative medicine products using proprietary collagen and synthetic polymers. Its technologies were widely adopted in cardiology, orthopedics, sports medicine, spine, endovascular procedures, and general surgery. The company was recognized for innovation in resorbable biomaterials.

Therapeutic areas: OtherCardiovascularNeurology
Modalities: DeviceCollagen-based biomaterialSynthetic polymer-based biomaterial
Industry: Surgical Medical Devices

Partnerships

St. Jude Medical (licensed manufacturer/distributor of Angio-Seal device)Strategic partners across multiple medical markets

Beyond the preview

Go deeper on Kensey Nash.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kensey Nash.

Explore the full profile